{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:28:26Z","timestamp":1792787306318,"version":"4.5.0"},"reference-count":63,"publisher":"BMJ","issue":"2","funder":[{"name":"NIH\/NCI","award":["R01CA235719"],"award-info":[{"award-number":["R01CA235719"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Tob Control"],"accepted":{"date-parts":[[2024,12,10]]},"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>IQOS was sold in the US in 2019\u20132021 and will likely return in 2024. It is important to anticipate IQOS\u2019 market penetration; thus, this study examined US adults\u2019 prior awareness and perceptions, intentions to try and reactions to an IQOS reduced-risk exposure statement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>61 adults from three US cities were recruited to represent four tobacco use subgroups: current cigarette and never electronic nicotine delivery systems (ENDS) use; current cigarette and discontinued ENDS use; current cigarette and ENDS use; and former cigarette use and switched to ENDS. Participants were shown IQOS marketing material and probed about IQOS awareness, knowledge, perceptions, use intentions and reactions to a reduced exposure statement. Analysis used a hybrid inductive\/deductive qualitative approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Participants reported low awareness and knowledge of IQOS and uncertainty about its functionality and health effects. Other impressions varied by subgroup. People who currently smoked but never tried ENDS reacted mostly negatively to IQOS; people who had switched to ENDS were disinterested in returning to \u2018real tobacco\u2019 use; people who currently used cigarettes and ENDS were curious but had mixed feelings; and people who had rejected ENDS exhibited the greatest interest but were concerned about perceived cost. Reactions to the reduced exposure statement were mixed; some groups viewed it as a meaningful endorsement of harm reduction benefits while others were sceptical.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Across tobacco use groups, there was varied interest and inclination to try IQOS and thus varied potential use as a complete substitute for cigarettes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/tc-2024-058854","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T13:20:49Z","timestamp":1735651249000},"page":"208-214","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Perceptions and intentions regarding IQOS among current US adults who use cigarettes and\/or electronic nicotine delivery systems"],"prefix":"10.1136","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3155-4041","authenticated-orcid":false,"given":"Scott R","family":"Weaver","sequence":"first","affiliation":[{"name":"School of Public Health, Georgia State University, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7869-5661","authenticated-orcid":false,"given":"Claire Adams","family":"Spears","sequence":"additional","affiliation":[{"name":"School of Public Health, Georgia State University, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9905-8648","authenticated-orcid":false,"given":"Katherine C","family":"Henderson","sequence":"additional","affiliation":[{"name":"School of Public Health, Georgia State University, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1060-5893","authenticated-orcid":false,"given":"David L","family":"Ashley","sequence":"additional","affiliation":[{"name":"TRS Consulting, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8931-1961","authenticated-orcid":false,"given":"Carla J","family":"Berg","sequence":"additional","affiliation":[{"name":"The George Washington University, Washington, District of Columbia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0856-5742","authenticated-orcid":false,"given":"Abigail T","family":"Evans","sequence":"additional","affiliation":[{"name":"Battelle, Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2429-1888","authenticated-orcid":false,"given":"Anna","family":"Geier","sequence":"additional","affiliation":[{"name":"Battelle, Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4872-8618","authenticated-orcid":false,"given":"Nikita","family":"Kute","sequence":"additional","affiliation":[{"name":"School of Public Health, Georgia State University, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4887-1254","authenticated-orcid":false,"given":"Terry F","family":"Pechacek","sequence":"additional","affiliation":[{"name":"School of Public Health, Georgia State University, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,12,31]]},"reference":[{"key":"2026102203551414000_35.2.208.1","doi-asserted-by":"publisher","DOI":"10.1136\/tobaccocontrol-2018-054601"},{"key":"2026102203551414000_35.2.208.2","doi-asserted-by":"publisher","DOI":"10.1136\/tobaccocontrol-2019-055488"},{"key":"2026102203551414000_35.2.208.3","unstructured":"Food and Drug Administration Center for Tobacco Products . Modified Risk Granted Orders. FDA; 2023. Available: https:\/\/www.fda.gov\/tobacco-products\/advertising-and-promotion\/modified-risk-granted-orders [Accessed 22 Apr 2024]."},{"key":"2026102203551414000_35.2.208.4","unstructured":"U.S. International Trade Commission . Certain tobacco heating articles and components thereof; commission\u2019s final determination finding a violation of section 337; issuance of a limited exclusion order and cease and desist orders; termination of the investigation. 86 FR 54998. Federal Register; 2021. Available: https:\/\/www.federalregister.gov\/documents\/2021\/10\/05\/2021-21626\/certain-tobacco-heating-articles-and-components-thereof-commissions-final-determination-finding-a"},{"key":"2026102203551414000_35.2.208.5","unstructured":"Philip Morris International . Philip Morris International Submits Applications to Commercialize IQOS ILUMA Tobacco Heating System to U.S Food and Drug Administration. Available: https:\/\/www.pmi.com\/media-center\/press-releases\/press-details [Accessed 23 Apr 2024]."},{"key":"2026102203551414000_35.2.208.6","unstructured":"Reuters . Philip Morris Signals Slower US Roll Out for IQOS. 2023. Available: https:\/\/www.reuters.com\/markets\/us\/philip-morris-expands-smoke-free-ambition-updates-targets-2023-09-28\/"},{"key":"2026102203551414000_35.2.208.7","unstructured":"Hanson A . British American Tobacco & Philip Morris International Settle Patent Dispute. Conv Store News 2024. Available: https:\/\/csnews.com\/british-american-tobacco-philip-morris-international-settle-patent-dispute"},{"key":"2026102203551414000_35.2.208.8","unstructured":"Rumney E . Exclusive: Philip Morris Nears Texas Launch of Flagship Heated Tobacco Device. Reut 2024. Available: https:\/\/www.reuters.com\/markets\/us\/philip-morris-nears-texas-launch-flagship-heated-tobacco-device-2024-03-28\/"},{"key":"2026102203551414000_35.2.208.9","unstructured":"Philip Morris International . Philip Morris International Reaches Agreement with Altria Group, Inc. to End the Companies\u2019 Commercial Relationship Covering IQOS in the U.S. Available: https:\/\/www.pmi.com\/media-center\/press-releases\/press-details [Accessed 23 Apr 2024]."},{"key":"2026102203551414000_35.2.208.10","unstructured":"Tobacco Reporter . PMI and BAT Settle Patent Disputes. Tobacco Reporter; 2024. Available: https:\/\/tobaccoreporter.com\/2024\/02\/02\/pmi-and-bat-settle-ip-disputes\/"},{"key":"2026102203551414000_35.2.208.11","unstructured":"Philip Morris delays U.S. heated tobacco device pilot to fourth quarter. Reut 2024."},{"key":"2026102203551414000_35.2.208.12","doi-asserted-by":"crossref","first-page":"04","DOI":"10.18332\/tpc\/144650","article-title":"Anticipating IQOS Market Expansion in the United States","volume":"8","author":"Abroms","year":"2022","journal-title":"Tob Prev Cessat"},{"key":"2026102203551414000_35.2.208.13","unstructured":"Food and Drug Administration . PM0000424. Tobacco Product Marketing Order; 2019. Available: https:\/\/www.fda.gov\/media\/124248\/download?attachment"},{"key":"2026102203551414000_35.2.208.14","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1001\/jamaoncol.2020.3316","article-title":"The Public Health Standard in Action\u2014Analysis of the US Food and Drug Administration\u2019s IQOS Review","volume":"6","author":"Berman","year":"2020","journal-title":"JAMA Oncol"},{"key":"2026102203551414000_35.2.208.15","doi-asserted-by":"publisher","DOI":"10.1136\/tobaccocontrol-2016-053462"},{"key":"2026102203551414000_35.2.208.16","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwy129"},{"key":"2026102203551414000_35.2.208.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1808779"},{"key":"2026102203551414000_35.2.208.18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S2213-2600(15)00521-4","article-title":"E-cigarettes and Smoking Cessation in Real-World and Clinical Settings: A Systematic Review and Meta-analysis","volume":"4","author":"Kalkhoran","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2026102203551414000_35.2.208.19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012680","article-title":"Electronic Nicotine Delivery Systems and\/or Electronic Non-nicotine Delivery Systems for Tobacco Smoking Cessation or Reduction: A Systematic Review and Meta-analysis","volume":"7","author":"El Dib","year":"2017","journal-title":"BMJ Open"},{"key":"2026102203551414000_35.2.208.20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129443","article-title":"Electronic Cigarettes Efficacy and Safety at 12 Months: Cohort Study","volume":"10","author":"Manzoli","year":"2015","journal-title":"PLoS One"},{"key":"2026102203551414000_35.2.208.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1607538"},{"key":"2026102203551414000_35.2.208.22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198047","article-title":"Are Electronic Nicotine Delivery Systems Helping Cigarette Smokers Quit? Evidence from a Prospective Cohort Study of U.S. Adult Smokers, 2015\u20132016","volume":"13","author":"Weaver","year":"2018","journal-title":"PLoS ONE"},{"key":"2026102203551414000_35.2.208.23","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/nty222"},{"key":"2026102203551414000_35.2.208.24","doi-asserted-by":"publisher","DOI":"10.7326\/M17-2048"},{"key":"2026102203551414000_35.2.208.25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1715757"},{"key":"2026102203551414000_35.2.208.26","doi-asserted-by":"publisher","DOI":"10.1177\/0033354917723597"},{"key":"2026102203551414000_35.2.208.27","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21413"},{"key":"2026102203551414000_35.2.208.28","unstructured":"U.S Food and Drug Administration . Searchable Tobacco Products Database. Available: https:\/\/www.accessdata.fda.gov\/scripts\/searchtobacco\/ [Accessed 7 Oct 2024]."},{"key":"2026102203551414000_35.2.208.29","unstructured":"Herzog B , Kanada P , Scott A . PM: The Best Is Yet To Come: IQOS Platform 2 Could Be Even More Promising Than Platform 1. New York, N.Y: Wells, 2017."},{"key":"2026102203551414000_35.2.208.30","unstructured":"Herzog B , Kanada P , Scott A , et al . IQOS in pictures: a visual overview of the global opportunity through 2025. Wells Fargo Securities; 2017."},{"key":"2026102203551414000_35.2.208.31","unstructured":"Philip Morris International . Philip morris international (pmi) files premarket tobacco product application for its electronically heated tobacco product (iqos) with the us food and drug administration (fda). Lausanne, Switzerland, 2017. Available: https:\/\/www.pmi.com\/investor-relations\/press-releases-and-events\/press-releases-overview\/press-release-details\/?newsId=2257952"},{"key":"2026102203551414000_35.2.208.32","doi-asserted-by":"publisher","DOI":"10.1136\/tobaccocontrol-2016-053264"},{"key":"2026102203551414000_35.2.208.33","doi-asserted-by":"publisher","DOI":"10.1136\/tobaccocontrol-2019-055306"},{"key":"2026102203551414000_35.2.208.34","doi-asserted-by":"publisher","DOI":"10.1111\/add.16051"},{"key":"2026102203551414000_35.2.208.35","doi-asserted-by":"publisher","DOI":"10.1136\/tobaccocontrol-2018-054390"},{"key":"2026102203551414000_35.2.208.36","doi-asserted-by":"publisher","DOI":"10.1136\/tobaccocontrol-2018-054322"},{"key":"2026102203551414000_35.2.208.37","doi-asserted-by":"crossref","DOI":"10.18332\/tid\/120103","article-title":"Gendered Factors for Heated Tobacco Product Use: Focus Group Interviews with Korean Adults","volume":"18","author":"Kim","year":"2020","journal-title":"Tob Induc Dis"},{"key":"2026102203551414000_35.2.208.38","doi-asserted-by":"publisher","DOI":"10.2188\/jea.JE20200213"},{"key":"2026102203551414000_35.2.208.39","first-page":"1023","article-title":"Awareness of Heated Tobacco Products among US Adults","volume":"43","author":"Karim","year":"2020","journal-title":"Health Inf Natl Trends Survey"},{"key":"2026102203551414000_35.2.208.40","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntac185"},{"key":"2026102203551414000_35.2.208.41","doi-asserted-by":"crossref","first-page":"8108","DOI":"10.3390\/ijerph17218108","article-title":"Unboxed: US Young Adult Tobacco Users\u2019 Responses to a New Heated Tobacco Product","volume":"17","author":"Kim","year":"2020","journal-title":"IJERPH"},{"key":"2026102203551414000_35.2.208.42","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntab058"},{"key":"2026102203551414000_35.2.208.43","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph20032016","article-title":"Heated Tobacco Products: Awareness, Beliefs, Use and Susceptibility among US Adult Current Tobacco Users, 2021","volume":"20","author":"Sparrock","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"2026102203551414000_35.2.208.44","doi-asserted-by":"publisher","DOI":"10.1136\/tobaccocontrol-2018-054323"},{"key":"2026102203551414000_35.2.208.45","unstructured":"Krueger RA . Focus groups: a practical guide for applied research. Sage publications, 2014."},{"key":"2026102203551414000_35.2.208.46","doi-asserted-by":"publisher","DOI":"10.1191\/1478088706qp063oa"},{"key":"2026102203551414000_35.2.208.47","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17238865","article-title":"What Motivates Smokers to Switch to ENDS? A Qualitative Study of Perceptions and Use","volume":"17","author":"Evans","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"2026102203551414000_35.2.208.48","doi-asserted-by":"publisher","DOI":"10.1093\/her\/cyae018"},{"key":"2026102203551414000_35.2.208.49","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7218a1"},{"key":"2026102203551414000_35.2.208.50","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1307484","article-title":"Exposure to IQOS Ads and Reduced Exposure Claims, and Association with Perceived Risk from COVID-19 on IQOS Purchase and Use Intentions: Results from a Web-based Survey","volume":"11","author":"Sharma","year":"2023","journal-title":"Front Public Health"},{"key":"2026102203551414000_35.2.208.51","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph20043141","article-title":"IQOS Use and Interest by Sociodemographic and Tobacco Behavior Characteristics among Adults in the US and Israel","volume":"20","author":"Levine","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"2026102203551414000_35.2.208.52","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntae093"},{"key":"2026102203551414000_35.2.208.53","doi-asserted-by":"publisher","DOI":"10.1093\/her\/cyac019"},{"key":"2026102203551414000_35.2.208.54","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-021-00490-8","article-title":"\u201cI Perceive It To Be Less Harmful, I Have No Idea If It Is Or Not:\u201d A Qualitative Exploration of the Harm Perceptions of IQOS among Adult Users","volume":"18","author":"East","year":"2021","journal-title":"Harm Reduct J"},{"key":"2026102203551414000_35.2.208.55","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntad096"},{"key":"2026102203551414000_35.2.208.56","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-49602-3"},{"key":"2026102203551414000_35.2.208.57","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntab094"},{"key":"2026102203551414000_35.2.208.58","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109569"},{"key":"2026102203551414000_35.2.208.59","doi-asserted-by":"publisher","DOI":"10.1136\/tc-2022-057613"},{"key":"2026102203551414000_35.2.208.60","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2018.304754"},{"key":"2026102203551414000_35.2.208.61","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.ssmph.2017.09.003","article-title":"Worldviews and Trust of Sources for Health Information on Electronic Nicotine Delivery Systems: Effects on Risk Perceptions and Use","volume":"3","author":"Weaver","year":"2017","journal-title":"SSM Popul Health"},{"key":"2026102203551414000_35.2.208.62","doi-asserted-by":"publisher","DOI":"10.1136\/tobaccocontrol-2018-054324"},{"key":"2026102203551414000_35.2.208.63","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntad187"}],"container-title":["Tobacco Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/tc-2024-058854","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:42:24Z","timestamp":1792694544000},"score":1,"resource":{"primary":{"URL":"https:\/\/tobaccocontrol.bmj.com\/lookup\/doi\/10.1136\/tc-2024-058854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,31]]},"references-count":63,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4,13]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1136\/tc-2024-058854"],"URL":"https:\/\/doi.org\/10.1136\/tc-2024-058854","relation":{},"ISSN":["0964-4563","1468-3318"],"issn-type":[{"value":"0964-4563","type":"print"},{"value":"1468-3318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,31]]}}}